Cresco Labs Inc.
CRLBF
$0.90
-$0.05-5.22%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -9.10% | -9.11% | -8.28% | -7.16% | -5.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.10% | -9.11% | -8.28% | -7.16% | -5.20% |
| Cost of Revenue | -9.83% | -7.95% | -4.21% | -6.73% | -9.52% |
| Gross Profit | -8.37% | -10.26% | -12.21% | -7.59% | -0.43% |
| SG&A Expenses | -3.65% | -1.42% | 0.49% | 1.47% | 0.13% |
| Depreciation & Amortization | -7.27% | -7.31% | -21.38% | -21.85% | -16.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.35% | -5.45% | -3.21% | -4.36% | -6.29% |
| Operating Income | -20.57% | -29.65% | -34.32% | -22.77% | 2.56% |
| Income Before Tax | -254.04% | -798.85% | -511.96% | 112.33% | 77.09% |
| Income Tax Expenses | -3.59% | -10.53% | -17.70% | 72.72% | 35.27% |
| Earnings from Continuing Operations | -92.52% | -131.52% | 9.64% | 77.52% | 52.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 177.69% | 133.24% | 86.49% | 12.71% | -1,659.05% |
| Net Income | -60.20% | -81.91% | 22.60% | 73.51% | 45.90% |
| EBIT | -20.57% | -29.65% | -34.32% | -22.77% | 2.56% |
| EBITDA | -18.57% | -25.42% | -29.53% | -21.03% | -3.75% |
| EPS Basic | -54.55% | -75.65% | 24.23% | 74.34% | 48.20% |
| Normalized Basic EPS | 198.87% | 224.76% | 231.33% | 175.64% | -235.31% |
| EPS Diluted | -54.55% | -75.65% | 24.23% | 74.34% | 48.20% |
| Normalized Diluted EPS | 198.87% | 224.76% | 231.33% | 175.64% | -235.31% |
| Average Basic Shares Outstanding | 3.13% | 2.76% | 2.55% | 2.69% | 4.40% |
| Average Diluted Shares Outstanding | 3.13% | 2.76% | 2.55% | 2.69% | 4.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |